Hologic Inc., a diversified diagnostic and medical product and device company, works with its subsidiaries to develop, manufacture and distribute medical imaging systems and surgical products designed to serve the healthcare needs of women. The Company’s core business units are focused on breast health, diagnostics, GYN surgical and skeletal health.
The Breast Health segment offers a broad portfolio of breast imaging and related products. The Diagnostic Products segment provides ThinPrep System, cervical cancer screening and Fetal Fibronectin Test for pre-term birth risk assessment. The GYN Surgical segment includes NovaSure Impedance Controlled RF Ablation system, a minimally-invasive procedure that allows physicians to treat women suffering from excessive menstrual bleeding. The Skeletal Health Segment includes dual-energy X-ray bone densitometers and ultrasound bone analyzers that address a growing market for osteoporosis prevention and treatment.
In October 2007, HOLX acquired Cytyc Corporation for approximately $6.2 billion to become one of the largest companies in the world focused on advanced technology in women’s health. Through this merger, the Company gained several other product lines, including tests to screen for cervical cancer, prenatal diagnostics, and radiation treatment of early-stage breast cancer. The acquisition made a substantial impact on HOLX’s revenues.
The Company has offices throughout Europe, the UK, Germany, France, Belgium, Italy and Spain, as well as in Australia, China and Canada. These offices handle sales, service, training and distribution to hospitals and clinical laboratories. HOLX markets its products through a combination of direct sales and service force, and a network of independent distributors and sales representatives. Founded about 20 years ago, the Company is headquartered in Bedford, Mass., and employs more than 4,000 employees worldwide.
Let us hear your thoughts: Hologic Inc. Message Board